152 related articles for article (PubMed ID: 15709880)
1. Management of hepatitis C virus-related arthritis.
Palazzi C; Olivieri I; Cacciatore P; Pennese E; D'Amico E
Expert Opin Pharmacother; 2005 Jan; 6(1):27-34. PubMed ID: 15709880
[TBL] [Abstract][Full Text] [Related]
2. An update on the management of hepatitis C virus-related arthritis.
Palazzi C; D'Amico E; D'Angelo S; Gilio M; Leccese P; Olivieri I
Expert Opin Pharmacother; 2014 Oct; 15(14):2039-45. PubMed ID: 25146875
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-related arthritis.
Palazzi C; D'Angelo S; Olivieri I
Autoimmun Rev; 2008 Oct; 8(1):48-51. PubMed ID: 18707027
[TBL] [Abstract][Full Text] [Related]
4. Management of hepatitis C virus-related arthritis.
Zuckerman E; Yeshurun D; Rosner I
BioDrugs; 2001; 15(9):573-84. PubMed ID: 11580301
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus and arthritis.
Olivieri I; Palazzi C; Padula A
Rheum Dis Clin North Am; 2003 Feb; 29(1):111-22. PubMed ID: 12635503
[TBL] [Abstract][Full Text] [Related]
6. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.
Caso F; Cantarini L; Morisco F; Del Puente A; Ramonda R; Fiocco U; Lubrano E; Peluso R; Caso P; Galeazzi M; Punzi L; Scarpa R; Costa L
Expert Opin Biol Ther; 2015 May; 15(5):641-50. PubMed ID: 25652590
[TBL] [Abstract][Full Text] [Related]
7. Consensus guidelines for the management of hepatitis C infection.
Consensus Guidelines Committee for the Management of Hepatitis C Infection
Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of interferon-gamma in course of hepatitis C virus-related arthritis.
Tarantino G; Sabatini P; Soriente I; Amato P; Sangiolo MG; Riccio A
J Interferon Cytokine Res; 2009 Jul; 29(7):389-92. PubMed ID: 19450146
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Lin KM; Cheng TT; Lin JC; Chen CJ
Clin Rheumatol; 2015 Jun; 34(6):1039-46. PubMed ID: 25939523
[TBL] [Abstract][Full Text] [Related]
10. Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C.
Niewold TB; Gibofsky A
Arthritis Rheum; 2006 Jul; 54(7):2335-7. PubMed ID: 16802375
[No Abstract] [Full Text] [Related]
11. Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
Paraná R; Schinoni MI; de Freitas LA; Codes L; Cruz M; Andrade Z; Trepo C
Liver Int; 2006 Nov; 26(9):1148-54. PubMed ID: 17032416
[TBL] [Abstract][Full Text] [Related]
12. Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis.
Conca P; Cafaro G; De Renzo A; Coppola A; Cimino E; Tarantino G
Int J Mol Sci; 2015 Jun; 16(6):14075-85. PubMed ID: 26101866
[TBL] [Abstract][Full Text] [Related]
13. Rheumatology meets hepatology in 2012: a clinician's guideline for TNF inhibitors in hepatitis B/C virus carriers.
Jansen TL; Mulder CJ
Expert Opin Biol Ther; 2012 Apr; 12(4):391-3. PubMed ID: 22413822
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus associated arthritis in absence of clinical, biochemical and histological evidence of liver disease--responding to interferon therapy.
Akhtar AJ; Funnyé AS
Med Sci Monit; 2005 Jul; 11(7):CS37-9. PubMed ID: 15990694
[TBL] [Abstract][Full Text] [Related]
15. Treatment of rheumatoid arthritis.
Gaffo A; Saag KG; Curtis JR
Am J Health Syst Pharm; 2006 Dec; 63(24):2451-65. PubMed ID: 17158693
[TBL] [Abstract][Full Text] [Related]
16. Disease characteristics and treatment patterns in veterans with rheumatoid arthritis and concomitant hepatitis C infection.
Patel R; Mikuls TR; Richards JS; Kerr G; Cannon GW; Baker JF
Arthritis Care Res (Hoboken); 2015 Apr; 67(4):467-74. PubMed ID: 25187185
[TBL] [Abstract][Full Text] [Related]
17. Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.
Vispo E; Barreiro P; Rodriguez-Nóvoa S; Morello J; Labarga P; Martín-Carbonero L; Maida I; García-Gascó P; Soriano V
Antivir Ther; 2008; 13(4):511-7. PubMed ID: 18672529
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha.
Zuckerman E; Keren D; Rozenbaum M; Toubi E; Slobodin G; Tamir A; Naschitz JE; Yeshurun D; Rosner I
Clin Exp Rheumatol; 2000; 18(5):579-84. PubMed ID: 11072597
[TBL] [Abstract][Full Text] [Related]
19. The role of anti-malarials in rheumatoid arthritis--the American experience.
Khraishi MM; Singh G
Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
[TBL] [Abstract][Full Text] [Related]
20. Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities.
Blackburn WD
Am J Med; 1996 Feb; 100(2A):24S-30S. PubMed ID: 8604723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
